Immunogenicity of a Heterologous Prime-Boost COVID-19 Vaccination with mRNA and Inactivated Virus Vaccines Compared with Homologous Vaccination Strategy against SARS-CoV-2 Variants

The emergence of SARS-CoV-2 variants may impact the effectiveness of vaccines, while heterologous vaccine strategy is considered to provide better protection. The immunogenicity of an mRNA-inactivated virus vaccine against the SARS-CoV-2 wild-type (WT) and variants was evaluated in the study. SARS-C...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ruiqi, Liu, Danlei, Leung, Ka-Yi, Fan, Yujing, Lu, Lu, Chan, Pui-Chun, To, Kelvin Kai-Wang, Chen, Honglin, Yuen, Kwok-Yung, Chan, Kwok-Hung, Hung, Ivan Fan-Ngai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781520/
https://www.ncbi.nlm.nih.gov/pubmed/35062734
http://dx.doi.org/10.3390/vaccines10010072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781520/
https://www.ncbi.nlm.nih.gov/pubmed/35062734
http://dx.doi.org/10.3390/vaccines10010072

Ejemplares similares